Aldo Nicosia

Prof. Dr. Aldo Nicosia

CNR-IRIB
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SRSalvatrice Silvia Rigogliuso
Salvatrice Silvia Rigogliuso
MSMonica Salamone
Monica Salamone
EBEnza Barbarino
Enza Barbarino
MBMaria Barbarino
Maria Barbarino
Aldo NicosiaAldo Nicosia
Aldo Nicosia
GGGiulio Ghersi
Giulio Ghersi
Cartilage is an avascular tissue with limited ability of self-repair. The use of autologous chondrocyte transplants represent an effective strategy for cell regeneration; however, preserving the differentiated state, which ensures the ability to regenerate damaged cartilage, represents the main challenge during in vitro culturing. For this purpose, we produced an injectable marine collagen-based hydrogel, by mixing native collagen from the jellyfish Rhizostoma pulmo with hydroxy-phenyl-propionic acid (HPA)-functionalized marine gelatin. This biocompatible hydrogel formulation, due to the ability of enzymatically reticulate using horseradish peroxidase (HPR) and H2O2, gives the possibility of trap cells inside, in the absence of cytotoxic effects, during the cross-linking process. Moreover, it enables the modulation of the hydrogel stiffness merely varying the concentration of H2O2 without changes in the concentration of polymer precursors. The maintenance of differentiated chondrocytes in culture was then evaluated via morphological analysis of cell phenotype, GAG production and cytoskeleton organization. Additionally, gene expression profiling of differentiation/dedifferentiation markers provided evidence for the promotion of the chondrogenic gene expression program. This, combined with the biochemical properties of marine collagen, represents a promising strategy for maintaining in vitro the cellular phenotype in the aim of the use of autologous chondrocytes in regenerative medicine practices.

25 October 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Aldo NicosiaAldo Nicosia
Aldo Nicosia
Gennara CavallaroGennara Cavallaro
Gennara Cavallaro
SCSalvatore Costa
Salvatore Costa
MUMara Utzeri
Mara Utzeri
Angela CuttittaAngela Cuttitta
Angela Cuttitta
Nicolò MauroNicolò Mauro
Nicolò Mauro
Background: Engineered luminescent carbon nanodots (CDs) are appealing nanomaterials for cancer image-guided photothermal therapy combining near infrared (NIR)–triggered hyperthermia, imaging, and drug delivery in a single platform for efficient killing of cancer cells. This approach would allow eliciting synergistic regulated cell death (RCD) routes such as necroptosis, targeting breast cancer cells refractory to apoptosis, thus overcoming drug resistance. Methods: We report the preparation of CDs bearing biotin as a targeting agent (CDs-PEG-BT), which are able to load high amounts of irinotecan (23.7%) to be released in a pulsed on-demand fashion. CDs-PEG-BT have narrow size distribution, stable red luminescence, and high photothermal conversion in the NIR region, allowing imaging of MDA-MB231 and MCF-7 cancer cells and killing them by photothermal and chemotherapeutic insults. Results: Cellular uptake, viability profiles, and RCD gene expression analyses provided insights about the observed biocompatibility of CDs-PEG-BT, indicating that necroptosis can be induced on-demand after the photothermal activation. Besides, photothermal activation of drug-loaded CDs-PEG-BT implies both necroptosis and apoptosis by the TNFα and RIPK1 pathway. Conclusions: The controlled activation of necroptosis and apoptosis by combining phototherapy and on-demand release of irinotecan is the hallmark of efficient anticancer response in refractory breast cancer cell lines in view of precision medicine applications.

1 July 2016 in Food Chemistry
Verified
Journal Article
Closed access
MTMarcello Tagliavia
Marcello Tagliavia
Aldo NicosiaAldo Nicosia
Aldo Nicosia
MSMonica Salamone
Monica Salamone
GBGirolama Biondo
Girolama Biondo
CBCarmelo Daniele Bennici
Carmelo Daniele Bennici
ACAngela Cuttitta
Angela Cuttitta

1 November 2014 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
Aldo NicosiaAldo Nicosia
Aldo Nicosia
MCMonica Celi
Monica Celi
MVMirella Vazzana
Mirella Vazzana
MDMaria Alessandra Damiano
Maria Alessandra Damiano
NPNicolò Parrinello
Nicolò Parrinello
ACAngela Cuttitta
Angela Cuttitta


27 June 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MSMonica Salamone
Monica Salamone
SRSalvatrice Silvia Rigogliuso
Salvatrice Silvia Rigogliuso
Aldo NicosiaAldo Nicosia
Aldo Nicosia
SCSimona Campora
Simona Campora
CBCarmelo Marco Bruno
Carmelo Marco Bruno
GGGiulio Ghersi
Giulio Ghersi
Adipose derived microvascular fragments (ad-MVFs) consist of effective vascularization units able to reassemble into efficient microvascular networks. Because of their content in stem cells and related angiogenic activity, ad-MVFs represent an interesting tool for applications in regenerative medicine. Here we show that gentle dissociation of rat adipose tissue provides a mixture of ad-MVFs with a length distribution ranging from 33–955 μm that are able to maintain their original morphology. The isolated units of ad-MVFs that resulted were able to activate transcriptional switching toward angiogenesis, forming tubes, branches, and entire capillary networks when cultured in 3D collagen type-I hydrogel. The proper involvement of metalloproteases (MMP2/MMP9) and serine proteases in basal lamina and extracellular matrix ECM degradation during the angiogenesis were concurrently assessed by the evaluation of alpha-smooth muscle actin (αSMA) expression. These results suggest that collagen type-I hydrogel provides an adequate 3D environment supporting the activation of the vascularization process. As a proof of concept, we exploited 3D collagen hydrogel for the setting of ad-MVF–islet of Langerhans coculture to improve the islets vascularization. Our results suggest potential employment of the proposed in vitro system for regenerative medicine applications, such as the improving of the islet of Langerhans engraftment before transplantation.